Ceramosides is a registered trademark of EPI France and is used under license from Seppic, Inc
For most people, the answer is yes, as long as its taken at recommended dosages and under the guidance of a healthcare professional
7583% achieved 15% 26% of participants on 12 mg achieved 30% weight reduction Cardiometabolic Parameters Improvements in blood pressure, HbA1c, fasting glucose, insulin, LDL-cholesterol 72% of patients with prediabetes achieved normoglycemia Safety Most common adverse events: gastrointestinal (nausea, diarrhea, constipation) , dose-dependent, predominantly mild to moderate Heart rate: slight increase up to week 24, then decrease No severe hypoglycemia, medullary carcinoma, or C-cell hyperplasia Conclusions Retatrutide induced significant, dose-dependent weight reduction of up to 24.2% over 48 weeks
Iron replacement $337 Targeted iron therapy designed to restore iron levels, support energy, and help you recover from fatigue faster
